Australia's facial injectables market was valued at USD1.8 billion in 2020. It is expected to grow at a compound annual rate (CAGR of 26.3%) between 2021 and 2028. The market is expected to grow due to increasing awareness of aesthetic procedures and a growing geriatric population. Market growth is expected to be supported by the following factors: the shift from invasive to minimally-invasive procedures, and advances in facial rejuvenation.
The combination of new products and advances in procedures will allow dermatologists to treat multiple facial areas. They can also customize treatments for each patient. These factors will contribute to Australia's growth in facial injectables over the forecast period.
Virtual consultations increased after the Covid-19 pandemic. The British Association of Aesthetic Plastic Surgeons reported a 70% increase in virtual consultation requests in the UK. The U.S. also reported an increase of 64% in requests for virtual consultations, which was due to patients considering treatment after the pandemic.
Wiley One Library reports that manufacturing companies in Taiwan, South Korea and the U.S. had to reduce the production of components for laser-based devices during the first and second quarters 2020. This affected the supply chain. This resulted in a decline in production for 2020.
The market for cosmeceuticals, or self-care, saw a lower impact during the pandemic because of an increase in online sales. However, invasive and minimally invasive markets such as aesthetic surgery, experienced a high impact due both to postponement and closure of facilities. The market for noninvasive treatments, such as injectable fillers or laser-based aesthetic treatment, saw a moderate to high impact. It is expected that it will rebound at a moderately-to-high rate.
The Hyaluronic Acid (HA), segment dominated the market, accounting for 54.9% of the total revenue in 2020. Due to its strong water retention and deep penetration into the epidermis, this segment is seeing increasing demand. Due to increased use of BoNTA cosmetics (esthetics) in cosmetics, for improving facial appearance and reducing signs of aging, the Botulinum Toxin type A segment will be the fastest-growing segment.
Cosmetic-grade HA is low in molecular weight. This allows for deep penetration into the epidermis. It helps in retaining water and releases antioxidants to slow down the aging process. HA can be used to heal burns, skin ulcers and wounds. It can also be used in plastic surgery as a lip filler. Due to an increase in HA's use as a dermal filler and in cosmetic injectables, the HA segment will dominate the market during the forecast period.
Australia's facial injectables market was dominated by the aesthetics segment. It accounted for over 70% in 2020, due to increased spending on aesthetic procedures as well as a growing awareness among consumers about aesthetic procedures. Over the forecast period, the therapeutic segment will see a double-digit increase in CAGR. This can be attributed to the increasing use of facial injections for treating blepharospasm or crossed eyes, Meige’s syndrome, Oromandibular Dystonia, Hemifacial Spasms, and focal hyperhidrosis.
A 26.5% CAGR is expected in the market for facial injections in Australia during the forecast period. This is due to increasing awareness and disposable income. Market growth will be supported by an increase in facial injectables for wrinkles, parentheses, lip lines, lip augmentation and lip border restoration.
To establish themselves in the market, market players are involved in numerous strategic alliances. In June 2021, SILK Laser Australia Limited signed an agreement to purchase Beauty Services Holdings Pty Ltd. This company operates two Australian Skin Clinics and one New Zealand Cosmetic Clinic. This acquisition will strengthen SILK's market position. Among the most prominent players in Australia's facial injectables market are:
SILK Laser Clinics
Advanced Clinics Australia
Laser Clinic Results
Australian Skin Clinics
Laser Clinics Australia
Up Market Research published a new report titled “Australia Facial Injectables Market research report which is segmented by Product (Botulinum Toxin Type A, Collagen, Calcium Hydroxylapatite, Hyaluronic Acid, Polymer Fillers), By Players/Companies Australian Skin Clinics, SILK Laser Clinics, Laser Clinics Australia, Results Laser Clinic, Advanced Clinics Australia”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Australia Facial Injectables Market Research Report |
By Product | Botulinum Toxin Type A, Collagen, Calcium Hydroxylapatite, Hyaluronic Acid, Polymer Fillers |
By Companies | Australian Skin Clinics, SILK Laser Clinics, Laser Clinics Australia, Results Laser Clinic, Advanced Clinics Australia |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 218 |
Number of Tables & Figures | 153 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product (Botulinum Toxin Type A, Collagen, Calcium Hydroxylapatite, Hyaluronic Acid, Polymer Fillers).
Australia Facial Injectables Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Australia Facial Injectables Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Australia Facial Injectables Market Report:
Some other reports from this category!